Despite parent's financial turbulence, subsidiary continues to secure major contracts Eviden continues to win supercomputer ...

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to ...

Detailed results from the KARISMA-Endoxifen trial demonstrating (Z)-endoxifen’s ability to significantly reduce mammographic breast density to be featured at conferenceSEATTLE, Nov. 20, 2024 ...

Atos has a 12-month low of $0.37 and a 12-month high of $8.53. The stock’s 50-day moving average price is $0.89 and its two-hundred day moving average price is $1.77. 10 Stocks to Sell NOW! 3 ...

Jaguar is rebranding itself, announcing a "new era" in an ethos tracing back to its founder, Sir William Lyons.

Penn State has won a closely watched trademark fight over an online retailer’s use of its vintage logos and images.

Jaguar’s brand image since 1982, the silhouette of a mid-leap feline, is now facing the opposite direction, into the fireless ...

The company showed four new elements, the Device Mark, the Strikethrough, the Exuberant Colors, and the Makers Marks, that ...

Car giant Jaguar has unveiled a new logo and a rebranded range of electric cars alongside marketing slogans such as “delete ...